Research: Heart patients can stop blood thinner when undergoing elective surgery
Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patient
Duke Human Vaccine Team awarded $5 million to study fungal fever
The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has been awarded a $5 million contract from the National Institute of Allergy and Infect
New study from Yancy, Oddone, Voils examines the effects of diet choice on weight loss
New research from a team including lead author William Yancy, MD (left), as well a
Faculty spotlight: John W. Williams, MD, MHSc
John W. Williams, MD, MHSc, is the subject of this week’s faculty spotlight.
Lantos discusses geospatial tools and analysis at Duke, Mongolia
This May, Paul Lantos, MD, gave two presentations on geospatial tools and analysis--one nearly 7,000 miles apart from the othe
Muir interviewed on local media about pill-form hepatitis C treatment
Andrew Muir, MD, chief of the Division of Gastroenterology and an expert in hepatitis, was interviewed by local television WNCN
Q & A with Kimberly Johnson: “We all have a role to play”
Kimberly Johnson, MD, associate professor of medicine (Geriatrics), is driven to reduce racial disparities in end-of-life care. Johnson is creating a new research program, which she will direct, on health disparities in palliative care among underserved populations. “I have always been deeply moved by the experiences of patients who are near the end of life,” Dr. Johnson said. “At some point, it became clear to me that this experience was different for African Americans.”